Nippon India Nifty Pharma ETF - Direct Plan
Copies an index like the Nifty 50 or Sensex. Low fees, no active fund manager, returns match the market. From Nippon India Mutual Fund. It's been running since 6 Jul 2021.
What ₹1 lakh would have become
Based on past returnsThese are calculations from the fund's past prices, not a prediction. Real future returns can and often do differ.
Play with a monthly investment
Slide the amount and switch the duration. Left column uses real past prices. Right column projects forward using this fund's historical rate — a calculation, not a prediction.
Vs 37 other funds in Other Scheme - Other ETFs
Descriptive rankings within the same category and plan. Not a recommendation — one fund beating another historically does not mean it will continue to do so.
Year by year
Calendar-year returns. 3 of last 6 years were positive.
Price over time
How the per-unit price has moved. Tap a range to zoom in.
Bumpiness & worst drops
The value swings roughly 15% up or down in a typical year. Finance-speak calls this volatility.
A lump sum invested at the previous peak would have temporarily lost about this much before recovering. Finance-speak calls this max drawdown.
Similar funds you might want to look at
Same category, same plan, sorted by 3-year return. Not recommendations — just neighbours.
Head-to-head comparisons
Side-by-side comparisons of Nippon India Nifty Pharma ETF - Direct Plan against other index funds.
Technical details (for the pros)
Fund info
- Fund house
- Nippon India Mutual Fund
- Category
- Other Scheme - Other ETFs
- Plan
- Direct
- Option
- —
- ISIN (Growth)
- INF204KC1089
- ISIN (Div re-invest)
- —
- Fund code
- 149008
- First price on record
- 6 Jul 2021 · 1,278 daily prices
About Nippon India Nifty Pharma ETF - Direct Plan
Nippon India Nifty Pharma ETF - Direct Plan is a Other Scheme - Other ETFs offered by Nippon India Mutual Fund under the Direct. It has approximately 5 years of NAV track record. The fund falls in the index category — Copies an index like the Nifty 50 or Sensex. Low fees, no active fund manager, returns match the market.
The current NAV of Nippon India Nifty Pharma ETF - Direct Plan is ₹27.2300 (as of 4 Sep 2026). Historically, it has delivered 21.26% over the last year, 21.20% CAGR over 3 years, 13.37% CAGR over 5 years. Returns are historical and don't predict future performance.
Over the last three years, the fund's prices have moved with 15.1% annualised volatility — a "high" level of bumpiness; its deepest peak-to-trough fall on record was 21.0%. Being mentally prepared for drawdowns of this size is what separates long-term investors from reactive traders.
Frequently asked
What is the latest NAV of Nippon India Nifty Pharma ETF - Direct Plan?+
The latest NAV of Nippon India Nifty Pharma ETF - Direct Plan is ₹27.2300 as of 4 Sep 2026, down 0.68% from the previous day. NAV is updated once a business day after the market close.
What are the returns of Nippon India Nifty Pharma ETF - Direct Plan?+
Nippon India Nifty Pharma ETF - Direct Plan has delivered 1-year return 21.26%, 3-year CAGR 21.20%, 5-year CAGR 13.37%, since-inception CAGR 13.12%. Returns are historical and don't predict future performance — markets move in cycles.
What category does Nippon India Nifty Pharma ETF - Direct Plan belong to?+
Nippon India Nifty Pharma ETF - Direct Plan is categorised as Other Scheme - Other ETFs. Copies an index like the Nifty 50 or Sensex. Low fees, no active fund manager, returns match the market.
How risky is Nippon India Nifty Pharma ETF - Direct Plan?+
Based on its 3-year annualised volatility of 15.1%, Nippon India Nifty Pharma ETF - Direct Plan sits in the "high" risk bucket. Volatility measures how much prices swing — higher means bigger ups and downs along the way.
Is Nippon India Nifty Pharma ETF - Direct Plan a direct plan?+
Nippon India Nifty Pharma ETF - Direct Plan is a Direct plan (no distributor commission — lower expense ratio).
How old is Nippon India Nifty Pharma ETF - Direct Plan?+
Nippon India Nifty Pharma ETF - Direct Plan has NAV history available from 6 Jul 2021 — approximately 5 years of track record and 1,278 daily NAV observations.
Numbers are computed from stored daily prices from mfapi.in/AMFI. This is descriptive analytics, not investment advice. Past performance is not indicative of future returns.